Twist Bioscience
TWST
49 hedge funds and large institutions have $138M invested in Twist Bioscience in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
4% more funds holding
Funds holding: 47 → 49 (+2)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
3% less capital invested
Capital invested by funds: $142M → $138M (-$3.79M)
1.36% less ownership
Funds ownership: 22.79% → 21.43% (-1.4%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$2.1M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.59M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$1.57M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$944K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$730K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$5.07M |
| 2 |
IP
Intellectus Partners
San Francisco,
California
|
-$4.08M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.81M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.16M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.05M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Norges Bank
Oslo,
Norway
| – | -$1.16M | -50,000 | Closed |
|
|
LCM
52
Landscape Capital Management
Englewood,
New Jersey
| – | -$1.05M | -45,521 | Closed |
|
|
DIM
53
DC Investments Management
Mclean,
Virginia
| – | -$990K | -42,858 | Closed |
|
|
LCM
54
Laurion Capital Management
New York
| – | -$924K | -40,000 | Closed |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$45 | +2 | New |
|
TWST Hedge Fund Activity: Q1 2019 in Review
49 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2019, worth a combined $138M — down 2.7% from $142M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TWST positions and 6 closed out — a net gain of 2 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $2.1M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $5.07M sold.
- 49 institutional investors held Twist Bioscience (TWST) as of Q1 2019, up from 47 in Q4 2018.
- Funds reported $138M of Twist Bioscience stock for Q1 2019, down 2.7% quarter-over-quarter.
- 8 funds opened new Twist Bioscience positions in Q1 2019 and 6 closed out, a net change of +2 holders.
- The largest Twist Bioscience buyer in Q1 2019 was JP Morgan Chase, an estimated $2.1M added.
- The largest Twist Bioscience seller in Q1 2019 was Massachusetts Financial Services, an estimated $5.07M sold.
Based on aggregated 13F filings for Q1 2019.